SUVOREXANT

SUVOREXANT was reported 13031 times

SUVOREXANT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SLEEP PARALYSIS 233 0.1586
1 LABELLED DRUG-FOOD INTERACTION ISSUE 6 0.0353
2 PRODUCT BLISTER PACKAGING ISSUE 30 0.0288
3 ABNORMAL SLEEP-RELATED EVENT 38 0.0288
4 HYPNAGOGIC HALLUCINATION 8 0.0262
5 CATAPLEXY 37 0.0261
6 GLOSSOPTOSIS 5 0.0228
7 ABNORMAL DREAMS 603 0.0218
8 SOMNAMBULISM 141 0.0215
9 NIGHTMARE 743 0.0214
10 CENTRAL HYPOTHYROIDISM 7 0.0211
11 PORIOMANIA 4 0.0209
12 DYSSOMNIA 4 0.0208
13 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 10 0.0200
14 HANGOVER 64 0.0182
15 OESOPHAGEAL DILATATION 8 0.0181
16 SLEEP-RELATED EATING DISORDER 16 0.0171
17 THERAPEUTIC RESPONSE INCREASED 15 0.0160
18 DRUG EFFECT PROLONGED 8 0.0145
19 TIME PERCEPTION ALTERED 5 0.0138
20 PERIODIC LIMB MOVEMENT DISORDER 5 0.0136
21 HEAT ILLNESS 9 0.0133
22 PLEUROTHOTONUS 11 0.0122
23 SLEEP TERROR 50 0.0119
24 IMMUNE-MEDIATED CHOLANGITIS 4 0.0111
25 AUTOSCOPY 6 0.0111
26 CONTRAINDICATED PRODUCT PRESCRIBED 18 0.0107
27 POOR QUALITY SLEEP 227 0.0105
28 TERMINAL INSOMNIA 18 0.0102
29 ANTEROGRADE AMNESIA 6 0.0100
30 BRAIN CONTUSION 7 0.0096
31 STOMA SITE HYPERGRANULATION 6 0.0095
32 MIDDLE INSOMNIA 177 0.0095
33 HYPERVIGILANCE 9 0.0093
34 SLEEP TALKING 15 0.0088
35 DRUG EFFECT VARIABLE 10 0.0088
36 INITIAL INSOMNIA 90 0.0088
37 CIRCADIAN RHYTHM SLEEP DISORDER 7 0.0084
38 SPONTANEOUS PENILE ERECTION 5 0.0081
39 DRUG EFFECT DELAYED 36 0.0079
40 THERAPEUTIC PRODUCT EFFECT INCREASED 9 0.0077
41 PHYSICAL DECONDITIONING 19 0.0074
42 PRODUCT PACKAGING DIFFICULT TO OPEN 19 0.0073
43 PARASOMNIA 5 0.0070
44 SEDATION COMPLICATION 17 0.0067
45 CUTANEOUS SYMPTOM 4 0.0058
46 NARCOLEPSY 11 0.0058
47 SUDDEN ONSET OF SLEEP 8 0.0058
48 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 5 0.0057
49 DISSOCIATIVE DISORDER 4 0.0055
50 LIP EROSION 4 0.0055
51 CHOLANGITIS ACUTE 4 0.0053
52 THERAPEUTIC PRODUCT EFFECT DELAYED 24 0.0053
53 TACHYPHRENIA 18 0.0052
54 RADIATION PNEUMONITIS 11 0.0051
55 HALLUCINATION 380 0.0050
56 THERAPEUTIC RESPONSE DELAYED 14 0.0050
57 LABELLED DRUG-DRUG INTERACTION ISSUE 7 0.0048
58 DELIRIUM 167 0.0048
59 STUPOR 15 0.0047
60 IMMUNE-MEDIATED HEPATIC DISORDER 9 0.0046
61 MARASMUS 7 0.0046
62 VANISHING BILE DUCT SYNDROME 5 0.0045
63 FACIAL SPASM 5 0.0045
64 MOANING 5 0.0044
65 ABULIA 4 0.0043
66 DRUG EFFECT INCOMPLETE 152 0.0042
67 ENTERITIS INFECTIOUS 7 0.0041
68 PARADOXICAL DRUG REACTION 15 0.0041
69 ALTERED STATE OF CONSCIOUSNESS 86 0.0040
70 INFECTIOUS PLEURAL EFFUSION 6 0.0039
71 AKINESIA 8 0.0039
72 STOMA SITE INFECTION 5 0.0038
73 ENURESIS 15 0.0037
74 CLAUSTROPHOBIA 4 0.0037
75 SOMNOLENCE 738 0.0037
76 CHRONIC GASTRITIS 8 0.0035
77 DIPLEGIA 7 0.0035
78 INABILITY TO AFFORD MEDICATION 35 0.0035
79 CANCER PAIN 9 0.0035
80 FEMORAL NECK FRACTURE 18 0.0035
81 PHOBIA 4 0.0035
82 SMALL INTESTINAL HAEMORRHAGE 7 0.0035
83 LOSS OF THERAPEUTIC RESPONSE 11 0.0034
84 JUDGEMENT IMPAIRED 5 0.0034
85 DEPRESSIVE SYMPTOM 12 0.0034
86 STEROID DIABETES 5 0.0033
87 SCREAMING 21 0.0033
88 POST-ACUTE COVID-19 SYNDROME 4 0.0032
89 PARALYSIS 46 0.0032
90 CARDIAC FAILURE CHRONIC 13 0.0030
91 FEELING DRUNK 22 0.0030
92 HYPOPITUITARISM 5 0.0029
93 EYE CONTUSION 6 0.0028
94 SLEEP DEFICIT 6 0.0028
95 FOOD INTERACTION 5 0.0028
96 FEELING JITTERY 54 0.0028
97 HALLUCINATION, AUDITORY 45 0.0028
98 SLEEP DISORDER 199 0.0028
99 HAEMORRHAGE SUBCUTANEOUS 10 0.0028
100 ASPHYXIA 23 0.0028
101 GASTROINTESTINAL NECROSIS 8 0.0027
102 CHOLANGITIS 17 0.0027
103 INTENTIONAL UNDERDOSE 20 0.0027
104 STOMA SITE ERYTHEMA 5 0.0027
105 PARKINSONISM 26 0.0027
106 SNORING 10 0.0026
107 DAYDREAMING 4 0.0026
108 INSOMNIA 688 0.0026
109 PSYCHIATRIC SYMPTOM 19 0.0026
110 RADIUS FRACTURE 6 0.0025
111 PANIC REACTION 18 0.0025
112 RESTLESS LEGS SYNDROME 45 0.0025
113 POOR QUALITY PRODUCT ADMINISTERED 26 0.0025
114 LIVER ABSCESS 8 0.0025
115 HEPATIC FUNCTION ABNORMAL 92 0.0025
116 ILLUSION 4 0.0024
117 HYPERVENTILATION 14 0.0024
118 BIPOLAR DISORDER 26 0.0024
119 PRODUCT SUPPLY ISSUE 17 0.0024
120 RESTLESSNESS 86 0.0023
121 SUSPECTED SUICIDE 11 0.0023
122 OCULOGYRIC CRISIS 5 0.0023
123 PANIC DISORDER 9 0.0023
124 PNEUMONIA ASPIRATION 58 0.0023
125 DRUG INEFFECTIVE 3050 0.0023
126 DRUG ERUPTION 41 0.0023
127 ADVERSE EVENT 208 0.0023
128 HYPERPHAGIA 9 0.0023
129 CARDIAC FAILURE ACUTE 15 0.0022
130 PRE-EXISTING CONDITION IMPROVED 14 0.0022
131 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 23 0.0022
132 COMPRESSION FRACTURE 12 0.0022
133 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 5 0.0022
134 THINKING ABNORMAL 41 0.0022
135 CONCUSSION 17 0.0022
136 NEUROLEPTIC MALIGNANT SYNDROME 26 0.0022
137 STOMA SITE DISCHARGE 6 0.0022
138 PSYCHOMOTOR HYPERACTIVITY 36 0.0022
139 DYSLIPIDAEMIA 11 0.0022
140 SUICIDAL BEHAVIOUR 9 0.0022
141 INCOHERENT 14 0.0022
142 NO ADVERSE EVENT 389 0.0021
143 IMPATIENCE 4 0.0021
144 LISTLESS 7 0.0021
145 AGITATION 156 0.0021
146 PEMPHIGOID 16 0.0021
147 TUMOUR HAEMORRHAGE 6 0.0021
148 ANXIETY DISORDER 7 0.0021
149 HYPERTONIC BLADDER 6 0.0021
150 PNEUMONIA BACTERIAL 19 0.0021
151 CEREBRAL INFARCTION 50 0.0020
152 FEELING ABNORMAL 489 0.0020
153 PYELONEPHRITIS ACUTE 4 0.0020
154 ERYTHEMA MULTIFORME 19 0.0020
155 MOVEMENT DISORDER 65 0.0020
156 THYROIDITIS 6 0.0020
157 CARDIAC DISCOMFORT 4 0.0020
158 FRUSTRATION TOLERANCE DECREASED 16 0.0020
159 HEAD DISCOMFORT 35 0.0020
160 LIBIDO INCREASED 4 0.0020
161 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 4 0.0020
162 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 12 0.0019
163 SPINAL COMPRESSION FRACTURE 16 0.0019
164 INTERSTITIAL LUNG DISEASE 93 0.0019
165 SEDATION 50 0.0019
166 NOCTURIA 23 0.0019
167 FORMICATION 13 0.0019
168 PRODUCT AVAILABILITY ISSUE 42 0.0018
169 POSTURE ABNORMAL 6 0.0018
170 DRUG EFFECT LESS THAN EXPECTED 27 0.0018
171 FEAR 49 0.0018
172 DEPRESSED LEVEL OF CONSCIOUSNESS 72 0.0018
173 SUSPECTED COVID-19 6 0.0018
174 PRESCRIBED OVERDOSE 35 0.0018
175 DRUG SCREEN FALSE POSITIVE 5 0.0018
176 TENSION 11 0.0018
177 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 61 0.0018
178 THERAPEUTIC PRODUCT EFFECT VARIABLE 7 0.0018
179 PULMONARY ALVEOLAR HAEMORRHAGE 10 0.0018
180 CONCOMITANT DISEASE AGGRAVATED 11 0.0018
181 DIVERTICULUM INTESTINAL HAEMORRHAGIC 4 0.0018
182 DRUG TOLERANCE 9 0.0018
183 HYPERSOMNIA 51 0.0018
184 DIZZINESS POSTURAL 17 0.0018
185 PNEUMATOSIS INTESTINALIS 5 0.0018
186 BENIGN PROSTATIC HYPERPLASIA 9 0.0017
187 ABNORMAL BEHAVIOUR 69 0.0017
188 NEPHROGENIC ANAEMIA 8 0.0017
189 LUMBAR SPINAL STENOSIS 5 0.0017
190 PRODUCT PACKAGING ISSUE 16 0.0017
191 SLEEP APNOEA SYNDROME 32 0.0017
192 LACUNAR INFARCTION 4 0.0017
193 SLUGGISHNESS 17 0.0017
194 LUNG ADENOCARCINOMA 5 0.0017
195 SCHIZOPHRENIA 20 0.0016
196 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 10 0.0016
197 ASPIRATION 18 0.0016
198 INTENTIONAL OVERDOSE 105 0.0016
199 INCORRECT DOSAGE ADMINISTERED 8 0.0016
200 INTESTINAL ISCHAEMIA 9 0.0016
201 ON AND OFF PHENOMENON 9 0.0016
202 URINARY RETENTION 53 0.0016
203 DRUG EFFECT INCREASED 5 0.0016
204 HAEMORRHAGE URINARY TRACT 4 0.0016
205 ENTEROCOLITIS 9 0.0016
206 HELICOBACTER INFECTION 16 0.0016
207 ENERGY INCREASED 9 0.0015
208 BRADYKINESIA 9 0.0015
209 PRESCRIBED UNDERDOSE 30 0.0015
210 DECUBITUS ULCER 12 0.0015
211 DERMATITIS EXFOLIATIVE GENERALISED 5 0.0014
212 SUICIDAL IDEATION 131 0.0014
213 ENDOTRACHEAL INTUBATION 4 0.0014
214 PHOTOPSIA 9 0.0014
215 MUSCLE CONTRACTIONS INVOLUNTARY 5 0.0014
216 MUSCLE FATIGUE 6 0.0014
217 APNOEA 11 0.0014
218 EATING DISORDER 30 0.0014
219 PRODUCT DISPENSING ISSUE 6 0.0014
220 DRUG LEVEL INCREASED 23 0.0014
221 FACIAL BONES FRACTURE 5 0.0014
222 FIBULA FRACTURE 4 0.0014
223 DYSPHORIA 7 0.0014
224 PRODUCT DOSE OMISSION 90 0.0014
225 HALLUCINATION, VISUAL 29 0.0014
226 PULMONARY PAIN 4 0.0014
227 IRRITABILITY 82 0.0014
228 ADVERSE REACTION 18 0.0014
229 PHYSICAL DISABILITY 6 0.0014
230 DYSKINESIA 55 0.0014
231 AMNESIA 88 0.0014
232 ILEUS PARALYTIC 6 0.0013
233 DEMENTIA 37 0.0013
234 REBOUND ACID HYPERSECRETION 4 0.0013
235 AKATHISIA 18 0.0013
236 ADRENAL INSUFFICIENCY 16 0.0013
237 HAEMOGLOBIN INCREASED 6 0.0013
238 PROSTATITIS 4 0.0013
239 DISSOCIATION 10 0.0013
240 BRUXISM 7 0.0013
241 BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0013
242 SUICIDE ATTEMPT 78 0.0013
243 MANIA 21 0.0013
244 PULMONARY TOXICITY 9 0.0013
245 PRODUCT USE COMPLAINT 20 0.0013
246 PYELONEPHRITIS 11 0.0013
247 EUPHORIC MOOD 13 0.0013
248 POLYDIPSIA 5 0.0013
249 HEAD INJURY 40 0.0013
250 SUBDURAL HAEMATOMA 18 0.0013
251 HEART RATE ABNORMAL 7 0.0013
252 IMPAIRED GASTRIC EMPTYING 17 0.0012
253 NIGHT SWEATS 40 0.0012
254 PRODUCT PRESCRIBING ISSUE 27 0.0012
255 VITAMIN B12 DEFICIENCY 5 0.0012
256 IMPAIRED DRIVING ABILITY 14 0.0012
257 SUDDEN DEATH 13 0.0012
258 THERAPEUTIC RESPONSE UNEXPECTED 55 0.0012
259 INJECTION SITE INFECTION 4 0.0012
260 CEREBRAL DISORDER 9 0.0012
261 HYPERURICAEMIA 5 0.0012
262 SPINAL STENOSIS 5 0.0012
263 METABOLIC DISORDER 7 0.0012
264 PALPITATIONS 141 0.0012
265 GASTROINTESTINAL PERFORATION 5 0.0012
266 DRY MOUTH 97 0.0012
267 COLITIS ISCHAEMIC 8 0.0012
268 PRODUCT LABEL ISSUE 8 0.0012
269 HEPATIC CYST 4 0.0012
270 AUTOIMMUNE HAEMOLYTIC ANAEMIA 4 0.0012
271 TENSION HEADACHE 5 0.0012
272 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 235 0.0012
273 DELUSION 18 0.0012
274 FUNCTIONAL GASTROINTESTINAL DISORDER 4 0.0012
275 LARGE INTESTINE POLYP 8 0.0012
276 PRODUCT USE ISSUE 217 0.0012
277 MICTURITION DISORDER 4 0.0012
278 LARGE INTESTINE PERFORATION 8 0.0012
279 MONOPLEGIA 5 0.0011
280 RHABDOMYOLYSIS 48 0.0011
281 LIVER DISORDER 51 0.0011
282 ORTHOSTATIC HYPOTENSION 20 0.0011
283 PRODUCT ADMINISTRATION INTERRUPTED 9 0.0011
284 DIVERTICULUM INTESTINAL 5 0.0011
285 RIGHT VENTRICULAR FAILURE 8 0.0011
286 DRUG SCREEN POSITIVE 9 0.0011
287 LOGORRHOEA 4 0.0011
288 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 10 0.0011
289 MYASTHENIA GRAVIS 9 0.0011
290 ANXIETY 317 0.0011
291 ANAL INCONTINENCE 10 0.0011
292 BLEPHAROSPASM 7 0.0011
293 BEHAVIOUR DISORDER 6 0.0011
294 SKIN LACERATION 12 0.0011
295 DEVICE KINK 4 0.0011
296 PANIC ATTACK 40 0.0011
297 CONTRAINDICATED PRODUCT ADMINISTERED 33 0.0011
298 HYPOMANIA 4 0.0011
299 PROSTATIC DISORDER 6 0.0011
300 RENAL IMPAIRMENT 91 0.0011
301 MENTAL IMPAIRMENT 26 0.0011
302 NO THERAPEUTIC RESPONSE 13 0.0011
303 RESPIRATORY DEPRESSION 13 0.0011
304 SENSORY DISTURBANCE 17 0.0011
305 CHOLECYSTITIS ACUTE 6 0.0011
306 SKIN ABRASION 5 0.0011
307 FACE INJURY 4 0.0011
308 TINNITUS 48 0.0010
309 POST-TRAUMATIC STRESS DISORDER 7 0.0010
310 INCONTINENCE 11 0.0010
311 HUMERUS FRACTURE 5 0.0010
312 FEEDING DISORDER 21 0.0010
313 ANGER 35 0.0010
314 ULCER HAEMORRHAGE 7 0.0010
315 UNDERDOSE 75 0.0010
316 THERAPEUTIC PRODUCT EFFECT DECREASED 46 0.0010
317 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 73 0.0010
318 COLD SWEAT 18 0.0010
319 NEPHROTIC SYNDROME 7 0.0010
320 MULTIPLE ALLERGIES 8 0.0010
321 CRYING 37 0.0010
322 RESPIRATION ABNORMAL 7 0.0010
323 GLUCOSE TOLERANCE IMPAIRED 6 0.0010
324 DIABETIC NEUROPATHY 5 0.0010
325 INFUSION SITE PAIN 13 0.0010
326 MYOCLONUS 12 0.0010
327 HYPERNATRAEMIA 5 0.0010
328 OBSESSIVE-COMPULSIVE DISORDER 8 0.0010
329 CARDIAC FAILURE 80 0.0010
330 COMPLETED SUICIDE 83 0.0010
331 NERVOUSNESS 52 0.0010
332 DISSEMINATED INTRAVASCULAR COAGULATION 14 0.0010
333 DRUG-INDUCED LIVER INJURY 31 0.0010
334 HOMICIDAL IDEATION 4 0.0010
335 INGUINAL HERNIA 6 0.0010
336 INSURANCE ISSUE 15 0.0010
337 PRODUCT COLOUR ISSUE 5 0.0010
338 ILEUS 12 0.0010
339 DERMATITIS CONTACT 11 0.0010
340 HEPATIC ENCEPHALOPATHY 9 0.0010
341 APATHY 14 0.0010
342 POLLAKIURIA 40 0.0010
343 ERECTION INCREASED 4 0.0010
344 MOOD ALTERED 26 0.0010
345 THIRST 17 0.0010
346 SENSITIVE SKIN 7 0.0009
347 BLOOD PRESSURE DECREASED 63 0.0009
348 DRUG PRESCRIBING ERROR 18 0.0009
349 DISORIENTATION 37 0.0009
350 OVERDOSE 199 0.0009
351 DRUG EFFECT DECREASED 49 0.0009
352 HYPOGLYCAEMIA 44 0.0009
353 DYSARTHRIA 34 0.0009
354 GASTRIC ULCER HAEMORRHAGE 5 0.0009
355 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 64 0.0009
356 HYPOPHAGIA 23 0.0009
357 SALIVARY HYPERSECRETION 9 0.0009
358 PULMONARY ARTERIAL HYPERTENSION 13 0.0009
359 MENTAL DISORDER 39 0.0009
360 ANGIOPATHY 5 0.0009
361 INTENTIONAL PRODUCT MISUSE 78 0.0009
362 SEROTONIN SYNDROME 17 0.0009
363 HEADACHE 549 0.0009
364 THERAPEUTIC RESPONSE DECREASED 53 0.0009
365 PRODUCT DOSE OMISSION ISSUE 257 0.0009
366 COLON CANCER 13 0.0009
367 DISTURBANCE IN ATTENTION 47 0.0009
368 HYPOKALAEMIA 40 0.0009
369 BLOOD CHOLESTEROL ABNORMAL 4 0.0009
370 PRODUCT DISTRIBUTION ISSUE 8 0.0009
371 SHOCK HAEMORRHAGIC 7 0.0009
372 AGGRESSION 43 0.0009
373 FEELING OF DESPAIR 4 0.0009
374 TOXIC EPIDERMAL NECROLYSIS 13 0.0009
375 PERIPHERAL SENSORY NEUROPATHY 5 0.0009
376 PLEURISY 5 0.0008
377 SPEECH DISORDER 44 0.0008
378 PROTHROMBIN TIME PROLONGED 5 0.0008
379 SUPRAVENTRICULAR TACHYCARDIA 8 0.0008
380 PRURITUS GENERALISED 18 0.0008
381 DEPRESSION 189 0.0008
382 FACIAL PARALYSIS 7 0.0008
383 HORMONE LEVEL ABNORMAL 4 0.0008
384 FALL 272 0.0008
385 ROAD TRAFFIC ACCIDENT 34 0.0008
386 PARANOIA 14 0.0008
387 CONFUSIONAL STATE 131 0.0008
388 MEMORY IMPAIRMENT 111 0.0008
389 TREMOR 134 0.0008
390 ORGANISING PNEUMONIA 4 0.0008
391 BLOOD CREATINE PHOSPHOKINASE INCREASED 23 0.0008
392 SWELLING OF EYELID 5 0.0008
393 HYPOAESTHESIA ORAL 12 0.0008
394 GLYCOSYLATED HAEMOGLOBIN INCREASED 20 0.0008
395 INTENTIONAL SELF-INJURY 16 0.0008
396 LOSS OF CONSCIOUSNESS 101 0.0008
397 DRUG DOSE OMISSION 130 0.0008
398 SUBARACHNOID HAEMORRHAGE 8 0.0008
399 MUSCULAR WEAKNESS 89 0.0008
400 GASTROINTESTINAL INFECTION 7 0.0008
401 MYOSITIS 7 0.0008
402 PHARYNGEAL OEDEMA 12 0.0008
403 SEIZURE 90 0.0008
404 ELECTROLYTE IMBALANCE 9 0.0008
405 INJECTION SITE INDURATION 10 0.0008
406 HYPERPROLACTINAEMIA 5 0.0008
407 VENTRICULAR EXTRASYSTOLES 8 0.0008
408 COVID-19 PNEUMONIA 9 0.0008
409 PULMONARY CONGESTION 10 0.0008
410 SCRATCH 8 0.0008
411 DEPRESSED MOOD 40 0.0008
412 DRUG INTERACTION 120 0.0008
413 CORONAVIRUS INFECTION 5 0.0008
414 CHOLECYSTITIS 9 0.0008
415 DRUG ADMINISTRATION ERROR 23 0.0007
416 GASTROINTESTINAL MOTILITY DISORDER 4 0.0007
417 ATRIOVENTRICULAR BLOCK COMPLETE 5 0.0007
418 METASTASES TO LYMPH NODES 5 0.0007
419 POISONING DELIBERATE 7 0.0007
420 INCREASED APPETITE 14 0.0007
421 EYE MOVEMENT DISORDER 5 0.0007
422 ESCHERICHIA INFECTION 6 0.0007
423 RIB FRACTURE 15 0.0007
424 HYPERCALCAEMIA 9 0.0007
425 APHASIA 22 0.0007
426 AFFECT LABILITY 7 0.0007
427 ECONOMIC PROBLEM 11 0.0007
428 ILL-DEFINED DISORDER 44 0.0007
429 AUTOIMMUNE HEPATITIS 5 0.0007
430 OCULAR DISCOMFORT 8 0.0007
431 THERAPY CHANGE 7 0.0007
432 PSYCHOTIC DISORDER 21 0.0007
433 URINARY INCONTINENCE 21 0.0007
434 DUODENAL ULCER 5 0.0007
435 LIGAMENT SPRAIN 7 0.0007
436 THERMAL BURN 5 0.0007
437 GENERALISED ERYTHEMA 4 0.0007
438 GRANULOCYTOPENIA 4 0.0007
439 VITAMIN D DECREASED 6 0.0007
440 MICTURITION URGENCY 8 0.0007
441 PNEUMOCYSTIS JIROVECII PNEUMONIA 7 0.0007
442 TOXIC SKIN ERUPTION 7 0.0007
443 MUSCLE TWITCHING 16 0.0007
444 HYPONATRAEMIA 39 0.0007
445 DRY THROAT 7 0.0007
446 FAECES SOFT 5 0.0007
447 DIZZINESS 341 0.0007
448 SPINAL OSTEOARTHRITIS 6 0.0007
449 FEELING OF BODY TEMPERATURE CHANGE 4 0.0007
450 LYMPHOCYTE COUNT DECREASED 12 0.0007
451 PURPURA 6 0.0007
452 BALANCE DISORDER 58 0.0007
453 MIGRAINE 64 0.0007
454 HAEMOLYTIC ANAEMIA 6 0.0007
455 HAEMORRHOIDS 13 0.0007
456 GENERALISED TONIC-CLONIC SEIZURE 11 0.0007
457 OROPHARYNGEAL DISCOMFORT 6 0.0007
458 ANGINA PECTORIS 19 0.0007
459 WRONG TECHNIQUE IN DRUG USAGE PROCESS 24 0.0007
460 BRADYCARDIA 35 0.0007
461 EPILEPSY 20 0.0007
462 MENISCUS INJURY 4 0.0006
463 HAEMOLYSIS 5 0.0006
464 DECREASED APPETITE 149 0.0006
465 ELECTROCARDIOGRAM QT PROLONGED 23 0.0006
466 LACERATION 6 0.0006
467 AFFECTIVE DISORDER 5 0.0006
468 MULTIPLE ORGAN DYSFUNCTION SYNDROME 18 0.0006
469 PNEUMOTHORAX 10 0.0006
470 STEVENS-JOHNSON SYNDROME 14 0.0006
471 ACCIDENTAL OVERDOSE 23 0.0006
472 MALNUTRITION 7 0.0006
473 COGNITIVE DISORDER 29 0.0006
474 GASTROENTERITIS 9 0.0006
475 CHOKING 12 0.0006
476 NEUTROPHIL COUNT DECREASED 25 0.0006
477 POLYURIA 5 0.0006
478 HAEMOPTYSIS 17 0.0006
479 HICCUPS 5 0.0006
480 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
481 DYSPHAGIA 57 0.0006
482 EOSINOPHIL COUNT INCREASED 5 0.0006
483 HYPERKALAEMIA 21 0.0006
484 PRODUCT QUALITY ISSUE 81 0.0006
485 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 106 0.0006
486 BLOOD PRESSURE FLUCTUATION 14 0.0006
487 PRODUCT CONTAINER ISSUE 5 0.0006
488 DYSSTASIA 17 0.0006
489 TEMPERATURE INTOLERANCE 6 0.0006
490 ONYCHOCLASIS 4 0.0006
491 MYOPATHY 5 0.0006
492 TENDERNESS 6 0.0006
493 LETHARGY 33 0.0006
494 EXPIRED PRODUCT ADMINISTERED 19 0.0006
495 GLAUCOMA 11 0.0006
496 SPINAL OPERATION 7 0.0006
497 BLOOD LACTATE DEHYDROGENASE INCREASED 9 0.0006
498 PAPULE 4 0.0006
499 JOINT DISLOCATION 6 0.0006
500 CHRONIC KIDNEY DISEASE 43 0.0006
501 MALAISE 248 0.0006
502 CEREBRAL HAEMORRHAGE 20 0.0006
503 DISABILITY 11 0.0006
504 DECREASED ACTIVITY 6 0.0006
505 HYPERHIDROSIS 71 0.0006
506 LIMB DISCOMFORT 17 0.0005
507 OESOPHAGITIS 6 0.0005
508 DEHYDRATION 73 0.0005
509 MOUTH HAEMORRHAGE 4 0.0005
510 ROTATOR CUFF SYNDROME 7 0.0005
511 SWOLLEN TONGUE 17 0.0005
512 METASTASES TO CENTRAL NERVOUS SYSTEM 7 0.0005
513 BLOOD PRESSURE DIASTOLIC DECREASED 4 0.0005
514 IRON DEFICIENCY ANAEMIA 5 0.0005
515 HYPOPHOSPHATAEMIA 4 0.0005
516 SKIN HAEMORRHAGE 8 0.0005
517 FEELING COLD 15 0.0005
518 HEART RATE INCREASED 53 0.0005
519 TUBULOINTERSTITIAL NEPHRITIS 10 0.0005
520 INCORRECT PRODUCT STORAGE 7 0.0005
521 BEDRIDDEN 7 0.0005
522 HYPOTHYROIDISM 17 0.0005
523 ORAL CANDIDIASIS 7 0.0005
524 ARTERIOSCLEROSIS 5 0.0005
525 SPINAL DISORDER 5 0.0005
526 CHEST DISCOMFORT 54 0.0005
527 HEPATOCELLULAR CARCINOMA 4 0.0005
528 HYPERTHERMIA 4 0.0005
529 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 5 0.0005
530 ACIDOSIS 4 0.0005
531 MUSCULOSKELETAL DISCOMFORT 9 0.0005
532 MULTIPLE SCLEROSIS 25 0.0005
533 TOXICITY TO VARIOUS AGENTS 88 0.0005
534 METASTASES TO LUNG 6 0.0005
535 ABDOMINAL DISCOMFORT 87 0.0005
536 SINUS CONGESTION 7 0.0005
537 ATRIOVENTRICULAR BLOCK 4 0.0005
538 FEMUR FRACTURE 16 0.0005
539 PRODUCT USE IN UNAPPROVED INDICATION 128 0.0005
540 APHTHOUS ULCER 4 0.0005
541 LIMB INJURY 14 0.0005
542 JOINT INJURY 11 0.0005
543 PALLOR 14 0.0005
544 GAIT DISTURBANCE 98 0.0005
545 THERAPY NON-RESPONDER 23 0.0005
546 GAIT INABILITY 17 0.0005
547 DRUG RESISTANCE 13 0.0005
548 BLOOD ALBUMIN DECREASED 4 0.0005
549 ORAL DISCOMFORT 7 0.0005
550 ACCIDENT 6 0.0005
551 INTENTIONAL PRODUCT USE ISSUE 44 0.0005
552 MUSCLE RIGIDITY 6 0.0005
553 HYPOTONIA 5 0.0005
554 CARPAL TUNNEL SYNDROME 7 0.0005
555 NAUSEA 395 0.0005
556 DEVICE OCCLUSION 7 0.0005
557 TARDIVE DYSKINESIA 14 0.0005
558 EMPHYSEMA 5 0.0005
559 SEASONAL ALLERGY 7 0.0005
560 HYPOAESTHESIA 74 0.0005
561 HYPERGLYCAEMIA 18 0.0005
562 MUSCLE DISORDER 4 0.0005
563 POST PROCEDURAL INFECTION 4 0.0005
564 LUNG DISORDER 24 0.0005
565 CARDIOMEGALY 6 0.0005
566 PARAESTHESIA ORAL 7 0.0005
567 MYELODYSPLASTIC SYNDROME 7 0.0005
568 HYPERTHYROIDISM 7 0.0005
569 MENSTRUAL DISORDER 4 0.0005
570 PERITONITIS 10 0.0005
571 CYTOMEGALOVIRUS INFECTION 8 0.0005
572 HEMIPLEGIA 4 0.0005
573 LIP SWELLING 16 0.0005
574 PNEUMONITIS 13 0.0005
575 CONSTIPATION 104 0.0005
576 CELLULITIS 24 0.0005
577 UPPER RESPIRATORY TRACT INFECTION 22 0.0005
578 FRACTURE 9 0.0005
579 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 26 0.0005
580 GASTRIC ULCER 9 0.0005
581 PULMONARY MASS 7 0.0005
582 FATIGUE 365 0.0005
583 IMPAIRED WORK ABILITY 10 0.0005
584 C-REACTIVE PROTEIN INCREASED 17 0.0005
585 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 12 0.0005
586 HERNIA 9 0.0005
587 NECK PAIN 26 0.0005
588 RASH GENERALISED 12 0.0005
589 DYSPHONIA 27 0.0005
590 EYE PAIN 26 0.0005
591 DRY EYE 23 0.0005
592 PLATELET COUNT DECREASED 49 0.0005
593 PYREXIA 159 0.0005
594 KIDNEY INFECTION 9 0.0005
595 DYSGEUSIA 34 0.0005
596 DEVICE RELATED INFECTION 7 0.0005
597 MELAENA 10 0.0005
598 EMOTIONAL DISORDER 14 0.0005
599 NEURALGIA 11 0.0005
600 DENTAL CARIES 5 0.0005
601 ASPARTATE AMINOTRANSFERASE INCREASED 24 0.0005
602 EAR INFECTION 12 0.0005
603 MALIGNANT NEOPLASM PROGRESSION 46 0.0004
604 CYTOKINE RELEASE SYNDROME 9 0.0004
605 PNEUMONIA 145 0.0004
606 SURGERY 26 0.0004
607 PRODUCT TASTE ABNORMAL 6 0.0004
608 HYPERTENSION 93 0.0004
609 END STAGE RENAL DISEASE 8 0.0004
610 BLOOD GLUCOSE DECREASED 21 0.0004
611 PERIPHERAL COLDNESS 6 0.0004
612 ANAEMIA 83 0.0004
613 GASTROOESOPHAGEAL REFLUX DISEASE 35 0.0004
614 INCREASED TENDENCY TO BRUISE 4 0.0004
615 DYSURIA 16 0.0004
616 DIABETES MELLITUS 33 0.0004
617 BLOOD POTASSIUM DECREASED 13 0.0004
618 MUSCLE TIGHTNESS 7 0.0004
619 HUNGER 6 0.0004
620 PERSONALITY CHANGE 4 0.0004
621 BACK DISORDER 7 0.0004
622 CARDIO-RESPIRATORY ARREST 18 0.0004
623 RENAL DISORDER 20 0.0004
624 WITHDRAWAL SYNDROME 18 0.0004
625 NEPHROPATHY 4 0.0004
626 APPENDICITIS 4 0.0004
627 URINARY TRACT INFECTION 73 0.0004
628 ANAPHYLACTIC SHOCK 11 0.0004
629 CONTUSION 41 0.0004
630 BLOOD PRESSURE INCREASED 65 0.0004
631 OSTEOARTHRITIS 18 0.0004
632 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
633 DIPLOPIA 11 0.0004
634 RESPIRATORY TRACT INFECTION 11 0.0004
635 BACTERAEMIA 5 0.0004
636 INTENTIONAL DOSE OMISSION 12 0.0004
637 PRODUCT PRESCRIBING ERROR 10 0.0004
638 ACUTE KIDNEY INJURY 64 0.0004
639 BLOOD UREA INCREASED 7 0.0004
640 MOBILITY DECREASED 30 0.0004
641 DIABETIC KETOACIDOSIS 10 0.0004
642 WEIGHT INCREASED 93 0.0004
643 HYPERCHOLESTEROLAEMIA 4 0.0004
644 NEPHROLITHIASIS 19 0.0004
645 SEPTIC SHOCK 18 0.0004
646 MUSCULOSKELETAL STIFFNESS 36 0.0004
647 CYTOPENIA 5 0.0004
648 ENCEPHALOPATHY 10 0.0004
649 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
650 SMALL INTESTINAL OBSTRUCTION 5 0.0004
651 CARDIOMYOPATHY 6 0.0004
652 HOSPICE CARE 4 0.0004
653 OSTEONECROSIS OF JAW 10 0.0004
654 ACTIVITIES OF DAILY LIVING IMPAIRED 8 0.0004
655 BLADDER DISORDER 4 0.0004
656 TOOTH EXTRACTION 5 0.0004
657 RESPIRATORY ARREST 11 0.0004
658 DIVERTICULITIS 11 0.0004
659 HYPOTHERMIA 4 0.0004
660 PLEURAL EFFUSION 24 0.0004
661 MULTIPLE SCLEROSIS RELAPSE 27 0.0004
662 DRUG LEVEL DECREASED 4 0.0004
663 MOTOR DYSFUNCTION 4 0.0004
664 ERECTILE DYSFUNCTION 10 0.0004
665 LUNG NEOPLASM MALIGNANT 16 0.0004
666 PERICARDIAL EFFUSION 9 0.0004
667 THYROID DISORDER 6 0.0004
668 LYMPHOMA 6 0.0004
669 ANKLE FRACTURE 6 0.0004
670 VOMITING 182 0.0004
671 MUSCLE SPASMS 71 0.0004
672 TOOTHACHE 7 0.0004
673 SEPSIS 43 0.0004
674 TRANSIENT ISCHAEMIC ATTACK 13 0.0004
675 EYE DISCHARGE 4 0.0004
676 TREATMENT NONCOMPLIANCE 21 0.0004
677 BRAIN FOG 6 0.0004
678 DIARRHOEA 245 0.0004
679 IMMUNE SYSTEM DISORDER 5 0.0004
680 AGRANULOCYTOSIS 7 0.0004
681 OBESITY 6 0.0004
682 HEPATIC STEATOSIS 7 0.0004
683 PHOTOPHOBIA 7 0.0004
684 BLOOD SODIUM DECREASED 7 0.0004
685 VISUAL IMPAIRMENT 46 0.0004
686 BURNING SENSATION 26 0.0004
687 FIBROMYALGIA 9 0.0004
688 BLOOD BILIRUBIN INCREASED 10 0.0004
689 THERAPY CESSATION 19 0.0004
690 THROAT TIGHTNESS 10 0.0004
691 PHARYNGITIS STREPTOCOCCAL 4 0.0004
692 FOOT FRACTURE 7 0.0004
693 PROTEINURIA 7 0.0004
694 RESPIRATORY DISORDER 11 0.0004
695 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
696 BLOOD ALKALINE PHOSPHATASE INCREASED 9 0.0004
697 PARAESTHESIA 57 0.0004
698 AGEUSIA 9 0.0004
699 MENTAL STATUS CHANGES 10 0.0004
700 NERVE INJURY 4 0.0004
701 ARRHYTHMIA 17 0.0004
702 ALANINE AMINOTRANSFERASE INCREASED 22 0.0004
703 APHONIA 5 0.0004
704 PANCYTOPENIA 20 0.0004
705 COMA 17 0.0004
706 FACE OEDEMA 6 0.0004
707 REBOUND EFFECT 4 0.0004
708 SINUS DISORDER 7 0.0004
709 UPPER LIMB FRACTURE 7 0.0004
710 INTERNATIONAL NORMALISED RATIO INCREASED 10 0.0004
711 CHOLECYSTECTOMY 4 0.0003
712 INTERNAL HAEMORRHAGE 4 0.0003
713 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
714 DYSPNOEA 198 0.0003
715 ABDOMINAL PAIN UPPER 72 0.0003
716 ATRIAL FIBRILLATION 34 0.0003
717 MYOCARDITIS 4 0.0003
718 HERPES ZOSTER 20 0.0003
719 SHOCK 8 0.0003
720 WEIGHT DECREASED 97 0.0003
721 EYE IRRITATION 20 0.0003
722 PRODUCT ADMINISTRATION ERROR 7 0.0003
723 DYSPEPSIA 34 0.0003
724 TASTE DISORDER 7 0.0003
725 VERTIGO 21 0.0003
726 BONE MARROW FAILURE 7 0.0003
727 HYPOKINESIA 5 0.0003
728 ARTHRITIS 27 0.0003
729 METASTASES TO LIVER 6 0.0003
730 MYALGIA 58 0.0003
731 DRUG WITHDRAWAL SYNDROME NEONATAL 5 0.0003
732 HEPATIC ENZYME INCREASED 23 0.0003
733 ATAXIA 4 0.0003
734 NEUROPATHY PERIPHERAL 32 0.0003
735 OEDEMA PERIPHERAL 41 0.0003
736 JAUNDICE 9 0.0003
737 KNEE ARTHROPLASTY 7 0.0003
738 OEDEMA 18 0.0003
739 HEPATIC FAILURE 10 0.0003
740 RENAL FAILURE 44 0.0003
741 OSTEOMYELITIS 6 0.0003
742 FUNGAL INFECTION 11 0.0003
743 SKIN DISORDER 11 0.0003
744 STOMATITIS 20 0.0003
745 OSTEOPENIA 5 0.0003
746 DISCOMFORT 20 0.0003
747 CARDIAC ARREST 27 0.0003
748 HIP ARTHROPLASTY 5 0.0003
749 ANAPHYLACTIC REACTION 18 0.0003
750 HYPOACUSIS 14 0.0003
751 BRONCHITIS 24 0.0003
752 WOUND 9 0.0003
753 BACTERIAL INFECTION 6 0.0003
754 GASTRIC DISORDER 11 0.0003
755 THERAPY PARTIAL RESPONDER 5 0.0003
756 INJECTION SITE DISCOLOURATION 4 0.0003
757 DYSPNOEA EXERTIONAL 12 0.0003
758 HOT FLUSH 24 0.0003
759 PAIN IN JAW 9 0.0003
760 HYPOCALCAEMIA 6 0.0003
761 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
762 MUSCLE ATROPHY 4 0.0003
763 PRURITUS 121 0.0003
764 OFF LABEL USE 275 0.0003
765 SCIATICA 5 0.0003
766 HEART RATE DECREASED 11 0.0003
767 CHEST PAIN 58 0.0003
768 PULMONARY OEDEMA 14 0.0003
769 MYDRIASIS 4 0.0003
770 ADVERSE DRUG REACTION 28 0.0003
771 PANCREATITIS ACUTE 7 0.0003
772 INCORRECT DOSE ADMINISTERED 71 0.0003
773 LYMPHADENOPATHY 11 0.0003
774 ERUCTATION 6 0.0003
775 RASH 135 0.0003
776 DYSTONIA 6 0.0003
777 HIATUS HERNIA 4 0.0003
778 PRODUCT STORAGE ERROR 27 0.0003
779 SWELLING FACE 20 0.0003
780 DEAFNESS 8 0.0003
781 ECZEMA 16 0.0003
782 ANHEDONIA 8 0.0003
783 VENTRICULAR TACHYCARDIA 5 0.0003
784 PHOTOSENSITIVITY REACTION 5 0.0003
785 HAEMATOCRIT DECREASED 6 0.0003
786 OXYGEN SATURATION DECREASED 17 0.0003
787 ILLNESS 31 0.0003
788 ASTHENIA 113 0.0003
789 COAGULOPATHY 5 0.0003
790 SYNCOPE 30 0.0003
791 HAIR TEXTURE ABNORMAL 4 0.0003
792 PAIN IN EXTREMITY 88 0.0003
793 NASOPHARYNGITIS 55 0.0003
794 JOINT RANGE OF MOTION DECREASED 4 0.0003
795 QUALITY OF LIFE DECREASED 4 0.0003
796 TACHYCARDIA 26 0.0003
797 HAEMATURIA 10 0.0003
798 CENTRAL NERVOUS SYSTEM LESION 4 0.0003
799 BLOOD CREATININE INCREASED 19 0.0003
800 COLITIS 11 0.0003
801 COUGH 81 0.0003
802 PULMONARY HYPERTENSION 6 0.0003
803 RESPIRATORY FAILURE 21 0.0003
804 INFLUENZA 32 0.0003
805 MASS 4 0.0003
806 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
807 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
808 DIABETES MELLITUS INADEQUATE CONTROL 5 0.0003
809 FLATULENCE 16 0.0003
810 RETCHING 6 0.0003
811 COVID-19 49 0.0003
812 GASTROENTERITIS VIRAL 5 0.0003
813 RASH PRURITIC 15 0.0003
814 VISION BLURRED 38 0.0003
815 FAECES DISCOLOURED 6 0.0003
816 ANOSMIA 4 0.0003
817 GASTRIC CANCER 7 0.0003
818 DEVICE DISLOCATION 12 0.0003
819 PRODUCT DISPENSING ERROR 6 0.0003
820 NEEDLE ISSUE 8 0.0003
821 CHOLELITHIASIS 9 0.0003
822 IMPAIRED HEALING 9 0.0003
823 EYE DISORDER 9 0.0003
824 CHILLS 32 0.0003
825 STAPHYLOCOCCAL INFECTION 9 0.0003
826 EXTRA DOSE ADMINISTERED 11 0.0003
827 ACUTE MYOCARDIAL INFARCTION 8 0.0003
828 VISUAL ACUITY REDUCED 9 0.0003
829 CONJUNCTIVITIS 5 0.0003
830 RENAL INJURY 8 0.0003
831 DRUG INTOLERANCE 26 0.0003
832 EYE SWELLING 10 0.0003
833 RASH PAPULAR 6 0.0003
834 ERYTHEMA 55 0.0003
835 BACK PAIN 62 0.0003
836 JOINT STIFFNESS 7 0.0003
837 CONDITION AGGRAVATED 81 0.0003
838 TREATMENT FAILURE 22 0.0003
839 HEART RATE IRREGULAR 6 0.0003
840 PAIN 163 0.0003
841 INTESTINAL OBSTRUCTION 10 0.0003
842 LACRIMATION INCREASED 8 0.0003
843 UNEVALUABLE EVENT 20 0.0003
844 SINUSITIS 27 0.0003
845 GASTROINTESTINAL HAEMORRHAGE 22 0.0003
846 MUSCULOSKELETAL DISORDER 5 0.0003
847 POST PROCEDURAL COMPLICATION 5 0.0003
848 ACUTE RESPIRATORY FAILURE 5 0.0003
849 OROPHARYNGEAL PAIN 24 0.0003
850 WHITE BLOOD CELL COUNT DECREASED 28 0.0003
851 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
852 FEBRILE NEUTROPENIA 17 0.0003
853 BONE PAIN 15 0.0003
854 INFLAMMATION 13 0.0003
855 MEDICATION ERROR 14 0.0003
856 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 12 0.0002
857 MUSCULOSKELETAL PAIN 13 0.0002
858 PRODUCT PHYSICAL ISSUE 5 0.0002
859 FLUSHING 25 0.0002
860 METASTASES TO BONE 4 0.0002
861 OSTEOPOROSIS 10 0.0002
862 INFECTION 35 0.0002
863 THERAPEUTIC RESPONSE SHORTENED 8 0.0002
864 LIVER FUNCTION TEST ABNORMAL 7 0.0002
865 ABDOMINAL DISTENSION 25 0.0002
866 TYPE 2 DIABETES MELLITUS 8 0.0002
867 HAEMATEMESIS 6 0.0002
868 WHEEZING 14 0.0002
869 BLOOD CHOLESTEROL INCREASED 11 0.0002
870 FLUID RETENTION 12 0.0002
871 WHITE BLOOD CELL COUNT INCREASED 9 0.0002
872 HOSPITALISATION 36 0.0002
873 URTICARIA 39 0.0002
874 BLISTER 13 0.0002
875 FEELING HOT 14 0.0002
876 ABDOMINAL PAIN 53 0.0002
877 TOOTH DISORDER 5 0.0002
878 GENERAL PHYSICAL HEALTH DETERIORATION 26 0.0002
879 CARDIAC DISORDER 21 0.0002
880 CYSTITIS 7 0.0002
881 MOOD SWINGS 7 0.0002
882 RHINORRHOEA 14 0.0002
883 DRUG ABUSE 18 0.0002
884 PERIPHERAL SWELLING 33 0.0002
885 EPISTAXIS 16 0.0002
886 GASTROINTESTINAL DISORDER 19 0.0002
887 OCULAR HYPERAEMIA 10 0.0002
888 BLOOD URINE PRESENT 4 0.0002
889 VIRAL INFECTION 7 0.0002
890 ARTHRALGIA 87 0.0002
891 CHOLESTASIS 4 0.0002
892 PANCREATIC CARCINOMA 6 0.0002
893 LOCALISED INFECTION 5 0.0002
894 ORAL HERPES 4 0.0002
895 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
896 HAEMOGLOBIN DECREASED 21 0.0002
897 ASTHMA 23 0.0002
898 CATARACT 12 0.0002
899 EXTRAPYRAMIDAL DISORDER 5 0.0002
900 BLOOD PRESSURE ABNORMAL 4 0.0002
901 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
902 PSORIATIC ARTHROPATHY 8 0.0002
903 PRODUCT PREPARATION ERROR 4 0.0002
904 HYPERSENSITIVITY 36 0.0002
905 SKIN ULCER 5 0.0002
906 HAEMATOMA 5 0.0002
907 DERMATITIS 4 0.0002
908 MOUTH ULCERATION 4 0.0002
909 PRODUCTIVE COUGH 9 0.0002
910 RASH ERYTHEMATOUS 9 0.0002
911 THROMBOCYTOPENIA 21 0.0002
912 HIP FRACTURE 6 0.0002
913 IRRITABLE BOWEL SYNDROME 4 0.0002
914 LIVER FUNCTION TEST INCREASED 4 0.0002
915 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
916 THERAPY INTERRUPTED 13 0.0002
917 INFUSION RELATED REACTION 12 0.0002
918 HYPOTENSION 36 0.0002
919 ORAL PAIN 4 0.0002
920 RED BLOOD CELL COUNT DECREASED 5 0.0002
921 CARDIAC FAILURE CONGESTIVE 14 0.0002
922 DRUG DEPENDENCE 28 0.0002
923 ALOPECIA 34 0.0002
924 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
925 BLINDNESS 7 0.0002
926 NASAL CONGESTION 10 0.0002
927 INFLUENZA LIKE ILLNESS 14 0.0002
928 DEEP VEIN THROMBOSIS 11 0.0002
929 CORONARY ARTERY DISEASE 5 0.0002
930 NEOPLASM MALIGNANT 11 0.0002
931 INJECTION SITE RASH 5 0.0002
932 RECTAL HAEMORRHAGE 7 0.0002
933 ARTHROPATHY 9 0.0002
934 ABASIA 4 0.0002
935 PRODUCT COMPLAINT 4 0.0002
936 EMOTIONAL DISTRESS 19 0.0002
937 INJURY 11 0.0002
938 HEPATITIS 4 0.0002
939 THROAT IRRITATION 7 0.0002
940 MYOCARDIAL INFARCTION 27 0.0002
941 LACTIC ACIDOSIS 5 0.0002
942 SKIN EXFOLIATION 13 0.0002
943 INCORRECT DOSE ADMINISTERED BY DEVICE 4 0.0002
944 SKIN DISCOLOURATION 7 0.0002
945 BLOOD GLUCOSE INCREASED 28 0.0001
946 FREQUENT BOWEL MOVEMENTS 4 0.0001
947 HAEMATOCHEZIA 8 0.0001
948 EXPOSURE DURING PREGNANCY 9 0.0001
949 DISEASE PROGRESSION 17 0.0001
950 DEATH 123 0.0001
951 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
952 INJECTION SITE ERYTHEMA 17 0.0001
953 THROMBOSIS 11 0.0001
954 ASCITES 4 0.0001
955 FOETAL EXPOSURE DURING PREGNANCY 11 0.0001
956 OESOPHAGEAL CARCINOMA 4 0.0001
957 COLITIS ULCERATIVE 6 0.0001
958 PSORIASIS 17 0.0001
959 CEREBROVASCULAR ACCIDENT 22 0.0001
960 NERVOUS SYSTEM DISORDER 4 0.0001
961 BONE DENSITY DECREASED 4 0.0001
962 PULMONARY EMBOLISM 12 0.0001
963 METABOLIC ACIDOSIS 4 0.0001
964 PROSTATE CANCER 10 0.0001
965 DEVICE BREAKAGE 5 0.0001
966 OSTEONECROSIS 4 0.0001
967 ACNE 9 0.0001
968 INJECTION SITE PAIN 36 0.0001
969 DEVICE LEAKAGE 5 0.0001
970 HAEMORRHAGE 12 0.0001
971 RASH MACULAR 4 0.0001
972 HYPOXIA 4 0.0001
973 PANCREATITIS 6 0.0001
974 MATERNAL EXPOSURE DURING PREGNANCY 10 0.0001
975 DEVICE ISSUE 10 0.0001
976 INJECTION SITE MASS 4 0.0001
977 SWELLING 10 0.0001
978 DISEASE RECURRENCE 5 0.0001
979 INJECTION SITE SWELLING 8 0.0001
980 PRODUCT SUBSTITUTION ISSUE 6 0.0001
981 DRUG WITHDRAWAL SYNDROME 9 0.0001
982 JOINT SWELLING 12 0.0001
983 DEPENDENCE 5 0.0001
984 INJECTION SITE PRURITUS 6 0.0001
985 RHEUMATOID ARTHRITIS 9 0.0001
986 DRY SKIN 10 0.0001
987 INJECTION SITE REACTION 5 0.0001
988 BLADDER CANCER 4 0.0001
989 NEUTROPENIA 9 0.0001
990 BREAST CANCER 6 0.0001
991 INJECTION SITE BRUISING 5 0.0001
992 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000